Log In
Print
BCIQ
Print
Print this Print this
 

VOLT01

  Manage Alerts
Collapse Summary General Information
Company Levolta Pharmaceuticals Inc.
DescriptionConjugated zoledronic acid combined with an undisclosed compound
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationOsteoarthritis
Indication DetailsTreat osteoarthritis (OA) of the knee
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today